CompletedPhase 4

Aflibercept With and Without Micropulse Laser in Diabetic Macular Edema

Kuwait51 participantsStarted 2017-05-08

Plain-language summary

prospective study evaluating the impact of subthreshold micropulsed laser on the number of Aflibercept injections when used as an adjuvant therapy in eyes with diabetic macular edema.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * older than 18 years old * diagnosed with DME with central macular thickness (CMT) more than 250 µm measured by OCT * best corrected visual acuity (BCVA) between 20/400 and 20/40. Exclusion Criteria: * patients with intra-ocular surgery as cataract surgery within 6 months * prior intravitreal injection of any drug within the preceding 6 months * panretinal photocoagulation (PRP) within the former 4 months. * Patients with previous macular laser * patients with vitreo-macular traction (VMT) syndrome * severe glaucoma * other retinal vascular diseases * conditions that impede the OCT interpretation

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

the number of intravitreal injections

Timeframe: 18th month follow-up.

Central macular thickness

Timeframe: 18 month

Trial details

NCT IDNCT03866746

SponsorAl Hadi Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-06-21

View on ClinicalTrials.gov More Diabetic Macular Edema trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.